CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients

Molecular Carcinogenesis

Volumn 53, Issue 9, 2014, Pages 686-697

  Cheng, Yuanyuan ^a   Tao, Lili ^a   Xu, Jiawen ^a   Li, Qingquan ^a   Yu, Juan ^a   Jin, Yiting ^b   Chen, Qi ^a   Xu, Zude ^a   Zou, Qiang ^b   Liu, Xiuping ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Chemotherapy; Invasion metastasis; Proliferation

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD147 ANTIGEN; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; GELATINASE A; GELATINASE B; HERMES ANTIGEN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PRION PROTEIN; ANTINEOPLASTIC AGENT; CD44 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MCF 7 CELL LINE; MEDULLARY CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; UPREGULATION; ADJUVANT THERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CELL MOTION; DRUG EFFECTS; DRUG RESISTANCE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

ADULT; ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; PRPC PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84906260359     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22021     Document Type: Article

References (36)

1. Staroselsky AN, Mahlin T, Savion N, et al. Metastatic potential and multidrug resistance correlation in the B16 melanoma system. J Exp Ther Oncol 1996; 1:251-259. [PubMed: 9414412].
2. Du J, Pan Y, Shi Y, et al. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113:213-220. [PubMed: 15386405].
3. Yang JM, Xu Z, Wu H, et al. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1:420-427. [PubMed: 12692261].
4. Reimers N, Zafrakas K, Assmann V, et al. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res 2004; 10:3422-3428. [PubMed: 15161697].
5. Li QQ, Wang WJ, Xu JD, et al. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 2004; 98:1064-1069. [PubMed: 17441962].
6. Li QQ, Wang WJ, Xu JD, et al. Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci 2007; 98:1767-1774. [PubMed: 17725804].
7. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62:385-427. [PubMed: 8102521].
8. Sharom FJ. ABC multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics 2008; 9:105-127. [PubMed: 18154452].
9. Miletti-González KE, Chen S, Muthukumaran N, et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in Cancer. Cancer Res 2005; 65:6660-6667. [PubMed: 16061646].
10. Pan Y, Zhao L, Liang J, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20:1886-1888. [PubMed: 16877520].
11. Li QQ, Cao XX, Xu JD, et al. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol Life Sci 2009; 66:504-515. [PubMed: 19099191].
12. Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997; 58:241-319. [PubMed: 9111868].
13. Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ. Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol 1999; 52:25-28. [PubMed: 10439835].
14. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4:33-45. [PubMed: 12511867].
15. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006; 66:10233-10237. [PubMed: 17079438].
16. Mouillet-Richard S, Ermonval M, Chebassier C, et al. Signal transduction through prion protein. Science 2000; 289:1925-1928. [PubMed: 10988071].
17. Graner E, Mercadante AF, Zanata SM, et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000; 76:85-92. [PubMed: 10719218].
18. Schmitt-Ulms G, Legname G, Baldwin MA, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314:1209-1225. [PubMed: 11743735].
19. Pan T, Wong BS, Liu T, et al. Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 2002; 368:81-90. [PubMed: 12186633].
20. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis. Nature 2008; 452:187-193. [PubMed: 18337816].
21. Xu JW, Li QQ, Tao LL, et al. Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells. Int J Oncol 2011; 39:1501-1509. [PubMed: 21805028].
22. Chetty C, Vanamala SK, Gondi CS, et al. MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 2011; 24:549-559. [PubMed: 22024282].
23. Mehrpour M, Codogno P. Prion protein: From physiology to cancer biology. Cancer Lett 2010; 290:1-23. [PubMed: 19674833].
24. Cordo-Russo RI, Alaniz LD, Saccodossi N, et al. Hyaluronan induces migration of multidrug-resistant lymphoma cell lines in vitro through Tiam1 activation by a PI3K-dependent mechanism. Leuk Res 2010; 34:1525-1532. [PubMed: 20299090].
25. Saxena M, Stephens MA, Pathak H, Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2011; 7:2:e179. [PubMed: 21734725].
26. Zhao Y, Sun X, Jiang L, et al. Differential expression of axl and correlation with invasion and multidrug resistance in cancer cells. Cancer Invest 2012; 30:287-294. [PubMed: 22489801].
27. Wang WJ, Li QQ, Xu JD, et al. Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells. Chemotherapy 2008; 54:291-301. [PubMed: 18689982].
28. Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol 2003; 36:60-65. [PubMed: 12542976].
29. Pardee AB. G1 events and regulation of cell proliferation. Science 1989; 246:603-608. [PubMed: 2683075].
30. Morgan DO. Principles of CDK regulation. Nature 1995; 374:131-134. [PubMed: 7877684].
31. Morgan DO. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13:261-291. [PubMed: 9442875].
32. Vey M, Pilkuhn S, Wille H, et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 1996; 93:14945-14949. [PubMed: 896216].
33. Zanata SM, Lopes MH, Mercadante AF, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307-3316. [PubMed: 12093732].
34. Meslin F, Conforti R, Mazouni C, et al. Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol 2007; 18:1793-1798. [PubMed: 17872899].
35. Gabus C, Derrington E, Leblanc P, et al. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem 2001; 276:19301-19309. [PubMed: 11278562].
36. Heske J, Heller U, Winklhofer KF, Tatzelt J. The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem 2004; 279:5435-5443. [PubMed: 14645231].